HCA Data Explorer

Decoding Human Megakaryocyte Development

Access Granted
Updated August 30, 2022

Despite our growing understanding of embryonic immune development, rare early megakaryocytes (MKs) remain relatively understudied. Here we used single-cell RNA sequencing of human MKs from embryonic yolk sac (YS) and fetal liver (FL) to characterize the transcriptome, cellular heterogeneity, and developmental trajectories of early megakaryopoiesis. In the YS and FL, we found heterogeneous MK subpopulations with distinct developmental routes and patterns of gene expression that could reflect early functional specialization. Intriguingly, we identified a subpopulation of CD42b+CD14+ MKs in vivo that exhibit high expression of genes associated with immune responses and can also be derived from human embryonic stem cells (hESCs) in vitro. Furthermore, we identified THBS1 as an early marker for MK-biased embryonic endothelial cells. Overall, we provide important insights and invaluable resources for dissection of the molecular and cellular programs underlying early human megakaryopoiesis.

Hongtao WangState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; CAMS Center for Stem Cell Medicine, PUMC Department of Stem Cell and Regenerative Medicine, Tianjin 300020, China.wanghongtao@ihcams.ac.cn
Changlu XuState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; CAMS Center for Stem Cell Medicine, PUMC Department of Stem Cell and Regenerative Medicine, Tianjin 300020, China.xuchanglu@ihcams.ac.cn
Jiaxi ZhouState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; CAMS Center for Stem Cell Medicine, PUMC Department of Stem Cell and Regenerative Medicine, Tianjin 300020, China.zhoujx@ihcams.ac.cn
Hongtao Wang1
Jian He2
Changlu Xu1
Xiaoyuan Chen1
Hua Yang3
Shujuan Shi3
Cuicui Liu1
Yang Zeng4
Dan Wu1
Zhijie Bai2
Mengge Wang1
Yuqi Wen1
Pei Su1
Meijuan Xia1
Baiming Huang1
Chunyu Ma5
Lihong Bian5
Yu Lan6
Tao Cheng1
Lihong Shi1
Bing Liu7
Jiaxi Zhou1
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; CAMS Center for Stem Cell Medicine, PUMC Department of Stem Cell and Regenerative Medicine, Tianjin 300020, China.
2State Key Laboratory of Proteomics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100071, China.
3Tianjin Central Hospital of Gynecology Obstetrics, Tianjin 300052, China.
4Laboratory of Experimental Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
5Department of Gynecology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China.
6Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China.
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; State Key Laboratory of Proteomics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100071, China; Laboratory of Experimental Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China; Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China.
Ida Zucchi
Ami Day

To reference this project, please use the following link:

https://explore.data.humancellatlas.org/projects/a9f5323a-ce71-471c-9caf-04cc118fd1d7
None
INSDC Project Accessions:GEO Series Accessions:INSDC Study Accessions:

Atlas

None

Analysis Portals

None

Project Label

MegakaryocyteDevelopment

Species

Homo sapiens

Sample Type

2 sample types

Anatomical Entity

3 anatomical entities

Organ Part

inner cell mass

Selected Cell Types

4 cell types

Model Organ

bone marrow

Disease Status (Specimen)

normal

Disease Status (Donor)

normal

Development Stage

10 development stages

Library Construction Method

2 library construction methods

Nucleic Acid Source

single cell

Paired End

false, true

Analysis Protocol

10x_analysis_protocol

File Format

5 file formats

Cell Count Estimate

18.7k

Donor Count

12
csv.gz4 file(s)fastq.gz4 file(s)fq24 file(s)fq.gz30 file(s)xlsx2 file(s)